此页面是自动翻译的,不保证翻译的准确性。请参阅 英文版 对于源文本。

Adjunctive Oral Probiotics in Endodontic Retreatment: Effects on Postoperative Pain and RANKL/OPG Levels (RANKL/OPG)

2026年7月1日 更新者:Amina Mamdouh Badawy、Ain Shams University

The Effect of Systemic Administration of Probiotics and Intra-Canal Medications on Level of Nuclear Factor Kappa B Ligand, Osteoprotegerin and Postoperative Pain in Patients With Chronic Apical Periodontitis: (Randomized Controlled Clinical Trial)

This study aimed to evaluate the effect of oral administration of probiotics as an adjunctive treatment to local intracanal medicaments, namely propolis and calcium hydroxide or empty canal, on the levels of receptor activator of nuclear factor kappa B ligand (RANKL) and osteoprotegerin (OPG), as well as on postoperative pain following root canal retreatment of teeth with chronic apical periodontitis

研究概览

详细说明

Post-treatment chronic apical periodontitis is an inflammatory condition caused by persistent microbial infection within the root canal system, characterized by progressive periapical bone destruction mediated by host immune-inflammatory mechanisms. Root canal retreatment remains the treatment of choice for failed endodontic cases; however, postoperative pain and incomplete resolution of inflammatory mediators remain common concerns. Clinical evidence demonstrates that postoperative pain following endodontic retreatment is influenced by microbial persistence, host inflammatory response, and intracanal medication protocols.

The RANK/RANKL/OPG axis is a key regulator of osteoclastic activity and periapical bone resorption. Elevated RANKL levels and altered RANKL/OPG ratio are associated with active periapical bone destruction. Modulation of this pathway may improve healing outcomes. Recent studies suggest that probiotics can regulate immune response, reduce inflammatory cytokines, and decrease RANKL expression.

This randomized clinical trial includes patients diagnosed with previously root-filled teeth presenting with chronic apical periodontitis indicated for non-surgical retreatment.

Standardized retreatment procedures are performed under aseptic conditions. Periapical exudate samples collected for biochemical analysis of RANKL and OPG levels at predetermined time points. Postoperative pain is assessed to investigate whether systemic probiotic administration can act as a host-modulating adjunct in endodontic retreatment and improve both symptomatic and biological healing outcomes.

研究类型

介入性

注册 (实际的)

72

阶段

  • 第四阶段

联系人和位置

本节提供了进行研究的人员的详细联系信息,以及有关进行该研究的地点的信息。

学习地点

    • Cairo Governorate
      • Cairo、Cairo Governorate、埃及、11566
        • Faculty of dentistry, Ain shams university

参与标准

研究人员寻找符合特定描述的人,称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。

资格标准

适合学习的年龄

  • 成人

接受健康志愿者

不

描述

Inclusion Criteria:

  • Previously treated failed single rooted teeth with chronic apical periodontitis.
  • No use of antibiotic three months before treatment.
  • Patients are free of any systemic disease.
  • Positive patient acceptance for participation

Exclusion Criteria:

  • Teeth that are badly broken down with difficult isolation.
  • Signs of acute infection, root fracture, root surface caries, swellings or ankylosis
  • Periodontally affected teeth with pockets deeper than 4mm.
  • Pregnant or lactating woman.
  • Patients who needs any prophylactic antibiotic.
  • Patients with allergy to pollen.

学习计划

本节提供研究计划的详细信息,包括研究的设计方式和研究的衡量标准。

研究是如何设计的?

设计细节

  • 主要用途:治疗
  • 分配:随机化
  • 介入模型:并行分配
  • 屏蔽:双倍的

武器和干预

参与者组/臂
干预/治疗
实验性的:Oral probiotics + Local Ca(OH)2 ICM
Following endodontic retreatment, calcium hydroxide placed as an intracanal medicament . Participants receive Linex Adult® (oral probiotics: Lactobacillus acidophilus, Bifidobacterium animalis ), one capsule daily for 21 days.
Linex Adult® is an oral probiotic formulation containing Lactobacillus acidophilus, Bifidobacterium animalis, It is administered as one capsule once daily for 21 days.
其他名称:
  • Lactobacillus acidophilus, Bifidobacterium animalis
Intracanal medication kept for 21 days
其他名称:
  • 元贴
实验性的:Oral probiotics + Local Propolis ICM
Following endodontic retreatment, propolis placed as an intracanal medicament. Participants receive Linex Adult® (oral probiotics: Lactobacillus acidophilus, Bifidobacterium animalis), one capsule daily for 21 days.
Linex Adult® is an oral probiotic formulation containing Lactobacillus acidophilus, Bifidobacterium animalis, It is administered as one capsule once daily for 21 days.
其他名称:
  • Lactobacillus acidophilus, Bifidobacterium animalis
Intracanal medication kept for 21 days
其他名称:
  • Intracanal propolis medicament
实验性的:Oral probiotics + Empty canal
Following endodontic retreatment, the canal was left empty without intracanal medicament. Participants received Linex Adult® (oral probiotics: Lactobacillus acidophilus, Bifidobacterium animalis), one capsule daily for 21 days.
Linex Adult® is an oral probiotic formulation containing Lactobacillus acidophilus, Bifidobacterium animalis, It is administered as one capsule once daily for 21 days.
其他名称:
  • Lactobacillus acidophilus, Bifidobacterium animalis
Empty canal for 21 days
其他名称:
  • No intracanal medicament
有源比较器:Oral placebo + Local Ca(OH)2 ICM
Following endodontic retreatment, Ca(OH)2 was placed as an intracanal medicament. Participants received placebo, one capsule daily for 21 days
Intracanal medication kept for 21 days
其他名称:
  • 元贴
Placebo capsule for 21 days
其他名称:
  • 匹配安慰剂
有源比较器:Oral placebo+ Local propolis ICM
Following endodontic retreatment, propolis was placed as an intracanal medicament. Participants received placebo, one capsule daily for 21 days
Intracanal medication kept for 21 days
其他名称:
  • Intracanal propolis medicament
Placebo capsule for 21 days
其他名称:
  • 匹配安慰剂
安慰剂比较:Oral placebo + Empty canal
Following endodontic retreatment, the canal was left empty without intracanal medicament. Participants received Linex Adult® (oral probiotics: Lactobacillus acidophilus, Bifidobacterium animalis), one capsule daily for 21 days.
Empty canal for 21 days
其他名称:
  • No intracanal medicament
Placebo capsule for 21 days
其他名称:
  • 匹配安慰剂

研究衡量的是什么?

主要结果指标

结果测量
措施说明
大体时间
The effect on RANKL and OPG levels in teeth with chronic apical periodontitis.
大体时间:(S1) measured in the first visit Immediately post-instrumentation and before ICM placement or oral supplement administration. (S2) After 21 days, immediately after removal of ICM and before obturation.
Level of RANKL and OPG measured with periapical samples (S1) and (S2) and analysed using ELISA test
(S1) measured in the first visit Immediately post-instrumentation and before ICM placement or oral supplement administration. (S2) After 21 days, immediately after removal of ICM and before obturation.

次要结果测量

结果测量
措施说明
大体时间
The effect on postoperative pain.
大体时间:Inter-appointment pain: baseline (start of the first visit), 4, 12, 24, 48, and 72 hours, and Week 1 and Week 2 after the first visit. Post-obturation pain: baseline (start of the second visit), 4, 12, 24, 48, and 72 hours after obturation.
Pain level measured using the Numeric Rating Scale (NRS), ranging from 0 (no pain) to 10 (worst possible pain), to evaluate inter-appointment pain between the first and second retreatment visits and post-obturation pain after the second retreatment visit and root canal obturation.
Inter-appointment pain: baseline (start of the first visit), 4, 12, 24, 48, and 72 hours, and Week 1 and Week 2 after the first visit. Post-obturation pain: baseline (start of the second visit), 4, 12, 24, 48, and 72 hours after obturation.

合作者和调查者

在这里您可以找到参与这项研究的人员和组织。

调查人员

  • 研究主任:Abeer A.Elhakim El Gendy, PHD, Professor of Endodontics、AinShams university

出版物和有用的链接

负责输入研究信息的人员自愿提供这些出版物。这些可能与研究有关。

研究记录日期

这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查,以确保它们在发布到公共网站之前符合特定的质量控制标准。

研究主要日期

学习开始 (实际的)

2025年10月4日

初级完成 (实际的)

2026年6月4日

研究完成 (实际的)

2026年6月20日

研究注册日期

首次提交

2026年6月26日

首先提交符合 QC 标准的

2026年7月1日

首次发布 (实际的)

2026年7月6日

研究记录更新

最后更新发布 (实际的)

2026年7月6日

上次提交的符合 QC 标准的更新

2026年7月1日

最后验证

2026年7月1日

更多信息

与本研究相关的术语

计划个人参与者数据 (IPD)

计划共享个人参与者数据 (IPD)?

不

药物和器械信息、研究文件

研究美国 FDA 监管的药品

不

研究美国 FDA 监管的设备产品

不

此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.

订阅